ADARx Pharmaceuticals, Inc. ADRX · SEC Filings

website

100

ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on devel...

Price13.8

Market Cap1.53 B

Float26.04 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B4

Form 424B4 - Prospectus [Rule 424(b)(4)]

Sep 25, 2026

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Sep 28, 2026

S-1MEF

OFFERING

Sep 24, 2026

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Sep 22, 2026

S-1/A

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Sep 21, 2026

S-1/A

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Sep 14, 2026

S-1

Form S-1 - General form for registration of securities under the Securities Act of 1933

Sep 4, 2026

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

LAV Biosciences Fund V, L.P. (Filed by)

Oct 16, 2026

SCHEDULE 13D

SR ONE CAPITAL MANAGEMENT, LLC (Filed by)

Oct 5, 2026

SCHEDULE 13D

ORBIMED ADVISORS LLC (Filed by)

Oct 2, 2026

SCHEDULE 13G

BCLS Fund III Investments, LP (Filed by)

Oct 1, 2026

Chimovits Erez (Reporting)

Sep 30, 2026

GORDON CARL L (Reporting)

Sep 30, 2026

Other

TYPE

HEADLINE

FILED AT